Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million
- Written by PR Newswire
Steps up R&D investment Focuses on precision medicine and intelligent testing sectors
HONG KONG, March 25, 2024 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year ended December 31, 2023 (the "Reporting...
Read more: Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million














